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Abstract: Analysis of electronic, structural and mechanistic parameters of the enzyme-substrate reaction of xanthine oxidase, a member of the 
xanthine dehydrogenase class of mono-molybdopterin oxidoreductive enzymes, shows that the molybdenum center in the enzyme active site 
acts as a reversible chiral switch. The metal center cycles from the (S)-absolute configuration, SPY-5-42-A, in the fully oxidized state, Mo(VI), to 
the (R)-absolute configuration, SPY-5-43-C, for the fully reduced metal center, Mo(IV). This process is complemented by induction of chirality 
at the substrate carbon center (pro-SC → SC) and is involved in the control of coordination and, likely, protonation of imino-centers of conjugated 
heterocyclic substrates in the enzyme active site. 
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ANTHINE dehydrogenase, XDH, [EC 1.17.1.4],[1] is the 
central member of the class of molybdopterin-
containing oxidoreductive metalloenzymes. Expressed in 
variety of tissues across the phylogenetic tree of organisms, 
the enzyme catalyses 2-electron oxidation of a range of C-
substrates.[2] Each of the C2-symmetry related 1333 amino-
acid peptide subunits, XDH_HUMAN,[3] in the enzyme 
homodimer houses four cofactors: (i) a phosphomolybdo 
pterin unit, MPT, Moco – the active site, (ii, iii) two 
ferredoxin-type iron-sulfur units, [2Fe-2S] and (iv) a flavin 
adenine dinucleotide unit, FAD.[2,4] In the course of a XDH-
catalyzed oxidative reaction the Mo(VI) center in the 
enzyme active site undergoes a 2-electron-equivalent 
reduction to Mo(IV) and, in the reverse half-cycle, two  
1-electron re-oxidations to the initial Mo(VI) state,[5,6] the 
redox reactions for the two half-cycles are given in Scheme 1. 
 With hypoxanthine and xanthine, the principal 
substrates in the rate-controlling terminal steps of the 
oxidative degradation of purine metabolites in mammals, 
the formal oxidation state of the target carbon atom, “x” in 
the Scheme 1a, is +2. Additionally, C-substrates with 
oxidation states x = –1,[7] and x = +1[8] are known to be on 
the enzyme substrate menu. 
 The two-electron equivalents passed from substrate 
to the Mo-center active site are then relayed to FADH and 
then to the terminal electron acceptor. In XDH this is 
nicotineamide adenine dinucleotide, NAD+.[9,10] With 
mammalian enzyme xanthine oxidase, XO, EC 1.17.3.2,[11] a 
member of the same class of enzymes derived from XDH 
either by reversible reduction/oxidation of a pair of Cys 
residues[12] or irreversible transformation by partial 
X 
(a)  Mo+6 + Cx → Mo+4 + Cx+2 
(b)  Mo+4 → Mo+5 + e– → Mo+6 + e– 
 
Scheme 1. (a) In the first half-cycle of the oxidoreductive 
reaction molybdenum center accepts 2 electrons from 
substrate and (b) in the second half-reaction molybdenum 
undergoes stepwise re-oxidation, forming in the process 
an experimentally detected Mo(V) species. (Note: The 
hydroxyl group transferred in the first half-cycle from 
enzyme to the substrate C-center does not change 
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proteolysis[13,14,15,16] dioxygen rather than the NAD+/NADH 
redox pair serves as terminal electron acceptor,[6] as 
illustrated by Scheme 2.  
 A two-point mutation in the XDH_HUMAN gene,[14] 
hXDH,[17–19] degrades the enzyme performance and results 
in the phenotypic xanthinuria-1 pathology (XAN1) while a 
co-deficiency of XDH and Aldehyde Oxidoreductase, 
AOXA_HUMAN,[20] another enzyme in the same class, or a 
genetically-induced deficiency in the Mo-pterin cofactor 
itself, causes xanthinuria type II (XAN2), a genetic 
deficiency resulting in a wide range, from asymptomatic to 
relatively mild, conditions. The deficiency of the 
molybdopterin cofactor in the related, sulfite oxidase, class 
of enzymes is a cause of imminent infant mortality.[21,22] 
 In the reactions catalyzed by the XO form of the 
enzyme [EC 1.17.3.2], generation of O2–. and H2O2 species 
introduces yet another set of biological variables, relating 
this class of enzymes with oxidative injury as well as the 
formation of the NO. hormone; this is apparently an aspect 
attracting progressively more attention and scrutiny.[23] 
 The relative stability of this class of proteins, their 
ubiquity and importance in humans, plants and bacteria[24–26] 
have attracted considerable research interest, starting with 
Franz Schardinger in as early as 1902[27] (hence the long-
standing name “Schardinger enzyme” for what was 
allegedly the XO form of the enzyme) or even earlier. The 
large opus of kinetic, molecular biological, UV/VIS, 
scattering and resonance Raman, ENDOR, ESEEM and EPR 
spectroscopic, and XAFS and x-ray structural, studies 
accrued over the past century has brought about significant 
advances in our understanding of the XDH class of enzymes. 
Here, I recognize and highlight another intrinsic property – 
the absolute configuration of the enzyme metal center – 
and introduce it as a novel and more precise descriptor of 
the enzyme structural and catalytic properties. 
 
RESULTS AND DISCUSSION 
Electronic structure calculations of enzyme models have 
brought a focused integration of the experimental evidence 
and provided a plausible picture of chemical-mechanistic 
parameters not amenable to experiment. Begun in part in 
1997 and 1998,[28–30] first-principles electronic structure 
calculation of the reaction transition state were 
subsequently carried out in a more systematic way,[31] 
starting from 46 completely random pair-coordination of 
enedithiolate model of molybdopterin center, 
LMo+6OS(OH) center (L = enedithiolate: –S–CH=CH–S–) and 
formamide (a bona fide enzyme substrate).[7] A first-order 
saddle point on the Mo-enedithiolate : formamide 
potential energy surface [PES] suggests a synchronous 
metathetic-type exchange between the enzyme Mo-center 
and the substrate C-center, without formation of an 
organometallic bond,[31] Scheme 3. The result was obtained 
using the Møller/Plesset’s method for perturbative 
correction of electron correlation (MP4//MP2[32] – i.e. 
fourth order energy correction using the structure 
optimized using the second MP order), with the double-
zeta Los Alamos basis set LanLDZ,[33,34] as implemented 
within the Gaussian computer program.[35] 
 In the calculations using the MP4//MP2 formalism 
for electron correlation correction the electron density on 
the substrate H-center shows a significant increase with the 
reaction progress, thus providing a strong support for the 
reaction model based on substrate-enzyme hydride 
transfer and a 2-electron reduction of the Mo center. It 
should be noted that this has not been the case in the 
calculations reported to use Density Functional Theory, 
DFT, methods, even for the DFT calculations using identical 
reaction model.[36] Subsequent calculations of the same 
reaction scenario[37] have branched out along approxi-
mately two principal directions. One direction followed an 
extension of the size of the Mo-enedithiolate : formamide 
model, from the initial 17-atom reaction pair,[28–31] to a 39 
atom model with the inclusion of xanthine substrate,[38] 
and to a 23357-atom cluster comprising, in addition to the 
enzyme-substrate reacting pair, solvent molecules treated 
by molecular mechanics, MM, methods.[39] The other 
direction was focused principally on the use of more 
refined and also more varied theoretical formalism, for 
example the CCSD(T) formalism[40,41] and a number of DFT 
methods. While expanding the theater of possible atomic 
XDH: FADH + NADP+ → FAD + NADPH 
XO: FADH + O2 → O2– + H2O2 
 
Scheme 2. In XDH the reduced flavin adenine dinucleotide 
cofactor, FADH, the terminal cofactor in the protein 
electron transfer relay line, passes two electrons to an 
oxidized nicotineamide adenine dinucleotide, as the 
terminal electron acceptor, while in XO the terminal two-
electron acceptor is dioxygen which then forms dioxygen 
radical anion and dioxygen dianion (hydrogen peroxide). 
 
Scheme 3. The topology of the enzyme-formamide 
substrate transition state: The enzyme Mo(VI) and the 
substrate C-center in +2 formal oxidation state (a) undergo 
a metathetic exchange which yields the enzyme Mo(IV) 
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exchange scenarios in the reactions catalyzed by this class 
of enzymes the results of these calculations have largely 
supported the geometry – if not the energy and the 
electron density distribution - of the transition state model 
presented in Scheme 3. 
 I deem a note on nomenclature to be appropriate at 
this point. Firstly, in virtually all mechanistic, structural and 
computational studies on the XDH class of enzymes the 
thioxo ligand, =S, has been consistently named “sulfide” 
thus confusing the ligand inventory in the oxidized, Mo(VI), 
with that of the reduced, Mo(IV), forms of the cofactor. 
Secondly, the hydron particle passed from a C-substrate to 
the =S ligand of the Mo-pterin center in the enzyme active 
site has been consistently named “proton” and the transfer 
has been designated as protonation. This is doubly wrong 
as, firstly, it conflates a Brønsted-acid-type reaction with a 
hydride transfer or hydridation and, secondly, it completely 
contradicts the currently accepted reaction mechanistic 
model for this class of enzymes. This is an unfortunate 
practice of promoting erroneous nomenclature and causing 
unnecessary confusion. 
 This geometry of a XDH : substrate transition state is 
posited to comprise a nearly planar pentagon subtended by 
the molybdenum center and its thioxo and hydroxyl ligands 
on the enzyme side and the carbon-hydride pair on the 
substrate side. The suggested scission of the Mo–O(H) and 
the formation of the S–H bonds on the enzyme side, and 
the scission of the C–H and the formation of the C–O(H) 
bonds on the substrate side, lead to a completion of the 
substrate oxidation and a separation of the reaction 
product. 
 A brief inspection of the reaction geometry and pair-
coordination, and the posited change in the character and 
position of the Mo ligands prompts a question about the 
chirality of the enzyme active site. Aside from a reference 
on the absolute configuration of the C(2)-center in the C6-
side-chain of a de-metalized 2-aminopteridine precursor / 
oxidation product[42] there have been no reported studies 
of the absolute configuration of the metal center in 
molybdopterin enzymes. Nor, seemingly, in other natural 
metalloenzymes. 
 A note of caution is needed at this point regarding 
the “correct” structure of the molybdopterin center as it 
has been reported for the XDH class of oxidoreductases. 
Firstly, for the correct ranking of molybdenum ligands we 
need to consider the complete molybdo-enedithiolato-
pyranopterin center Figure 1, as the Mo-enedithiolate 
model of the enzyme active site used successfully in the 
energy profile calculations, Scheme 1, does not provide 
sufficient structural information. 
 This point requires additional scrutiny as the position 
of the thioxo ligand, Mo = S, in the enzyme molybdopterin 
cofactor has not been well defined in a number of protein 
crystal x-ray diffraction experiments; this was either 
because the x-ray diffraction was collected from a sample 
of de-sulfo enzyme form[43] or the experimental electron 
densities on the oxo and sulfoxo ligands were not 
sufficiently discernible.[44] One consequence of this 
uncertainty is that the molecular models used in numerous 
electronic structure studies of Mo-enedithiolate or Mo-
enedithiolate : substrate reported since 1996 are either 
rotamers-enantiomers[45] or enantiomers of the correct 
structure;[28–31,36,46,47] in at least one report the correct 
structure is given in the article but enantiomers are 
provided in the supplementary material.[36] The recent 
reports on the crystal structure of XOR with an inhibitor[48] 
and the crystal structure of quinoline 2-oxidoreductase, 
QOR,[49] have brought this important issue to closure. Here, 
I use a consensus of the molybdenum center structures 
reported for the bovine milk inhibitor-bound xanthine 
dehydrogenase, PDB ID codes 3UNA[16] and 1FO4,[48] 
xanthine oxidase, PDB ID code 1FIQ,[13] and the bacterial 
quinoline 2-xidoreductase, PDB ID code 1T3Q.[49] The 
structure of this molybdopterin cofactor is defined by a 
pyramidal Mo-enedithiolate ring, cata-condensed with 
pyranopterine; the four-ring cofactor is twisted to assume 
M-helicity [M = minus]. The molybdenum oxo ligand, 
Mo=O, is apical and the hydroxyl, Mo-OH, and thioxo, 
Mo=S, ligands are equatorial. The methylphospho, –CH2–
OPO3R, substituent at the position C2’ of the pyrano ring is 
cis- to the Mo=O apical ligand; the structure of this cofactor 
is given in Step #1 below. 
 When determining the absolute configuration of the 
metal center in the Mo-pterin active site of the XDH class 
of enzymes, I note that the original CIP rule provides no 
guidance, stating specifically: “However, since we know of 
no molecule whose chirality depends on that of a 
configurationally stable, chiral, quinqueligant atom, we 
shall for the present refrain from detailing such a 
 




hydroxy)molybdate, C10H10N5O7PS3Mo [CAS RN: 9002-17-9 
(dioxo form)], viewed “from above”, that is, along the O=Mo 




442 P. ILICH: Xanthine Dehydrogenase Active Site … 
 




procedure”.[50] So I resorted to the early works delineating 
an extension of the CIP rules[51,52] and the current rules for 
the structure and nomenclature of inorganic complexes, 
given in the so-called “Red Book 2005”,[53] referred to as 
“Recommendations” in this text. Given the possible 
broader didactic benefits I present the procedure applied 
here in full detail, Step #1 through Step #6. 
 
 Step #3: The geometry of the complex is determined 
to be 5-coordinate square pyramidal, SPY-5, according to 
the Table IR-9.3 of Recommendations. 
 Step #4: According to the Rule IR-9.3.3.5 of 
Recommendations, the configuration index of the Mo(VI) 
center is determined to be 42. The first digit, 4, is the 
priority ranking of the axial ligand (=O, #4) pointing to the 
metal center (along the axis of observation) and the second 
digit, 2, is the priority ranking of the ligand (Sb, #2) which is 
trans- to the highest priority ligand, the thioxo group (=S, 
#1). So the designation of the geometry and the 
configuration index of the O=MoVI(=S)SaSb(OH) complex is 
SPY-5-42.[53,54] 
 Step #5: According to Recommendations (IR-9.3.4.6), 
The C/A convention for square pyramidal centres, the 
clockwise and anticlockwise sequences of priority numbers 
are compared and the structure is assigned the symbol C or 
A according to whether the clockwise (C) or anticlockwise 
(A) sequence is lower at the first point of difference. The 
point of difference in the Mo-pterin center is ligand #3, the 
lower ranking dithiolate sulfur; see also Scheme 4a. The 
path from #1 to #3 is anti-clockwise (counter-clockwise), A, 
and the path from #2 to #3 is clockwise, C. Since 1 + 3 = 4 is 
a lower numbered sequence than 2 + 3 = 5, the prevalent 
configuration is A. So the Mo-center has left-handed absol-
ute configuration and its full designation is SPY-5-42-A. 
 
 The same absolute configuration for the Mo(VI) 
center in XDH has been derived using a different 
methodology.[51,52] 
 Step #6: The preceding Mo-pterin coordination is 
that of the oxidized, reaction-ready Mo(VI) center in the 
active site of xanthine and aldehyde oxidoreductive 
enzymes, XDH, AOXA, XO, XOR. Following the metathetic 
exchange with substrate, Scheme 3, the Mo(VI)-center 
loses the O(H) ligand to the substrate to become a two-
electron-reduced Mo(IV) tetrahedral complex,[31,41] (a), or, 
as invoked in early mechanistic considerations and suggested 
by some x-ray structural studies[43] a 5-coordinated aqua-
Mo(IV) complex (b): 
 The tetrahedral Mo(IV) complex is of R-absolute 
configuration and the 5-coordinated aqua complex could 
be shown to posses the SPY-5-43-C absolute configuration. 
Both centers are right-handed. As the full oxidoreductive 
 
Step #1. Abstraction of a full monophosphomolybdopterin, 
MPT, (a) to a 5-coordinated molybdenum center (b) with 
clearly designated dithiolate sulfur centers, Sa and Sb. 
 
Step #2. In the geometrical (a) and topological (b) 
representation of the Mo-center the ligands are ranked 
and numbered according to the CIP rule:[50] the Sa sulfide, 
being closer to the pyrano oxygen (3rd tier, see Step #1), 
has a higher rank than Sb sulfide and is assigned higher 
priority while the Sb sulfide, closer to the pyrazine nitrogen 
(3rd tier), is assigned lower priority. 
 
Step #5. The Mo(VI)-pterin center geometrical abstraction 
(a) and the absolute configuration of its topological 
representation (b), SPY-5-42-A. 
Step #6. The enzyme Mo-center and its topological 
representation, immediately following separation of 
reaction product (a), and the same center, Mo(IV), after 
acquisition of a water molecule (which is 
thermodynamically preferred to hydroxyl group) and its 
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cycle involves both the Mo(VI) and Mo(IV) states of the 
enzyme active site I postulate the following: 
The molybdenum center of the Mo-pterin complex in 
the active site of the xanthine dehydrogenase 
enzyme acts in the course of a complete 
oxidoreductive cycle as a reversible chiral switch. 
 And how does this relate to the spatial distribution 
of the atomic centers in the enzyme substrates and 
products? Given the type of chemical transformation of the 
substrate carbonyl carbon and the transient topology of the 
enzyme-substrate complex one could argue that the 
relative orientation of substrate may not be of particular 
importance to the reaction outcome. With formamide as 
substrate the transition state topology, Scheme 3, would 
allow for a possibility of two enzyme – substrate 
coordination: one in which the apical Mo=O fragment in the 
enzyme center and the C-N fragment in the substrate are 
anti-, inducing (S)-chirality in the substrate carbon center, 
Figure 2a, and another, where the same two molecular 
fragments are syn-, giving rise to an (RC) – transition state 
configuration of the substrate carbon atom, Figure 2b. In the 
following, I will call these two coordination anti-transition 
state, anti-TS, and syn-transition state, syn-TS, respectively. 
 Only the interacting geometries defined by the anti-TS 
coordination have led to a true transition state in the course 
of the electronic structure calculations of the Mo-
enedithiolate : formamide molecular pair, using the 
MP2/LanL2DZ formalism.[31] Simulated reaction trajectories 
starting with the syn-TS type input geometries, Figure 2b, 
do not result in a transition state but typically drift toward 
a complete separation of a chemically unchanged substrate 
and the enzyme cofactor. This may at first seem surprising 
given a possibility for the intermolecular Mo=O ··· HNH 
hydrogen bonding interaction that could potentially 
facilitate formation of the transitions state. With this idea 
in mind, a number of syn-TS input geometries were created 
with the (enzyme)=O ··· H-(substrate) intermolecular 
distance ranging from 220 pm (weakly interacting) to 160 
pm (medium-to-strongly interacting). However, none of 
these coordination resulted in a transition state. 
 Further analysis indicated that this may be not a 
result of a numerical coincidence only. In the course of 
spatial and electronic changes leading to a transition state 
the following changes occur in the formamide substrate 
molecule: (i) a significant twisting of the H–C=O plane  
(~ 42°) with respect to the HNH moiety, (ii) a partial loss of 
the carbonyl sp2 character, and (iii) a slight elongation of 
the C–N bond (from 132 pm to 138 pm). As demonstrated 
by NMR spectroscopic studies of peptides,[55,56] a donating 
hydrogen-bonding interaction of an amido hydrogen 
induces the opposite effect - an increase in the C–N bonding 
character. Hydrogen-bonding interaction between the 
enzyme Mo=O and the substrate H–N, as anticipated for 
the syn-TS coordination, Figure 2b, would therefore be 
disruptive to the electronic structure changes formamide is 
undergoing in the course of oxidative hydroxylation. On the 
enzyme cofactor side, neither would a hydrogen-bonding 
interaction accepted by the Mo(VI)-coordinated oxo group, 
the so-called “spectator” oxygen,[57,58] be expected to pro-
mote the transition state formation as the resulting partial 
loss of the Mo=O oxo character would have lead to a 
decreased nucleophilicity of the Mo-coordinated cis-
hydroxyl group, as indicated by the electron density 
distribution in our calculations.[31,46] It should be clear that, 
these arguments notwithstanding, the results of our 
transition state calculations could be of no more 
significance than a fortuitous outcome of a numerical 
simulation executed within a relatively narrow window of 
atomic and geometric parameters and within a specific 
theoretical formalism. A more careful analysis, however, 
does indicate a possible emergence of a pattern. 
 Translated to simple chemical terms the results of 
our calculations suggest an accumulation of the negative 
charge on the hydrogen atom and an increase in the C-H 
bond polarization in formamide. As pointed early on, the 
transfer of hydride from substrate to the Mo(VI)=S 
fragment of the enzyme cofactor is the principal reaction 
coordinate and constitutes the formal transfer of two 
reducing equivalents from substrate to the enzyme. 
Calculations with oxo-congeners of the enzyme 
molybdopterin center,[46,39,41] on the one hand, and the 
formamide thioxo-congener substrate, on the other hand 
[Ilich & Hille, unpublished calculations], show that absent 
any of the changes associated with the substrate carbon 
atom re-hybridization the oxidoreductive reaction will not 
take place in either case. It should also be noted that in 
formamide – a small, simple and relatively flexible 
molecule[59] – the electronic structure changes leading to 
formation of transition state are centered on the target 
carbon atom. In case of larger, conjugated heterocyclic, 
substrates and inhibitors (purines, quinoline, allopurine, 
and pteridine and pyridine derivatives) the analogous 
 
Figure 2 The absolute configuration of the substrate C-
center (not shown in the tetrahedral representation) in (a) 
the anti-TS coordination, and the absolute configuration of 
the C-center in (b) the syn-TS coordination (note that in the 
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electronic structure changes will depend also on the 
participation of the atoms adjacent to the target carbon 
center. 
 Protonation, even partial, of the nitrogen vicinal to the 
target carbon will facilitate the electronic structure changes 
leading to sp2 – sp3 rehybridization in, for example, the 
quinoline C2 and the hypoxanthine C2 centers (see Figures 3 
and 4 for atom labeling). This imposes another condition on 
the formation of the transition state: a requirement for a 
properly positioned proton donor within the enzyme active 
site. The quinoline 2-oxidoreductase : quinoline pair seems 
particularly well suited to illustrate this point. The target 
atom, C2 in the quinoline ring, can be coordinated in the 
enzyme active site so that the C=N bond is either syn- or anti- 
to the molybdopterin Mo=O fragment, Figure 3a & 3b. 
 Only the anti-coordination, Figure 3a, will lead to a 
formation of the transition state and the oxidative 
hydroxylation of the ring at C2, as suggested by analysis 
presented here and confirmed by a high-resolution x-ray 
diffraction study of the QOR : quinoline complex.[49] 
 Quinoline is in spite of its size a relatively simple 
molecule that provides a good demonstration for the 
principle of anti-TS orientation of the substrate imino 
fragment and the Mo=O group in the enzyme active site. In 
larger and more complicated substrates other factors, like 
the size of the substrate molecule, its effective volume, the 
presence of multiple intranuclear nitrogen centers and 
multiple extranuclear carbonyl groups could be envisaged 
as dominant secondary factors in the formation of the 
transition state. I illustrate this aspect in the case of 
hypoxanthine, the penultimate product of the metabolic 
degradation of nucleic acids in mammals and the principal 
substrate for the XO form of this class of enzymes. The 
product of the XO-catalyzed oxidative hydroxylation of 
hypoxanthine (or purine-6-one) is xanthine (or purine-2,6-
dione) and the enzyme-substrate coordination pattern I 
have identified in this class of enzymes leads to two 
possible transition state geometries, Figure 4a & 4b. 
 While no direct experimental evidence for a 
transition state is available, the recent x-ray diffraction 
studies of the XO protein crystals treated with 
hypoxanthine suggest the enzyme : substrate coordination 
given in Figure 4b as the likely pre-transition state reaction 
geometry.[60,61] I proffer three interpretations of this 
structure: (i) the anti-TS coordination condition for the 
oxomolybdenum : imino fragments is not valid in the case 
of purine substrates, (ii) the x-ray diffraction data for the 
protein : substrate co-crystal do not directly relate to the 
enzyme : substrate transition state, and (iii) the substrate is 
selected for a certain predominant proto-tautomeric form 
in the reaction course. 
 I posit that the first assumption is likely not valid 
given the evidence I have presented. The second 
assumption – while of potential relevance in numerous other 
studies – is in principle impossible to evaluate. This leaves 
us with the third assumption. Heterocyclic aromatic 
compounds like purines and pteridines (the latter are left 
out from the present consideration) are known, by both 
experiment and numerical simulations,[62,63,64] to exist in 
multiple proto-tautomeric forms which easily exchange 
under the effects of immediate environment. If the x-ray 
evidence for the two proto-tautomers of dry and wet 
guanine, respectively,[65,66] is any guidance I conclude that 
the transition state depicted in Figure 4b forms as a result 
of the anti-TS coordination requirement accommodated 
with a specific hypoxanthine proto-tautomeric form selected 
by the reaction conditions within the XO active site. 
 It is interesting to note another thread common to 
the structures presented in Figures 3 and 4 and also shared 
with the Mo-enedithiolate : formamide transition state, 
 
 
Figure 3 Two a priori possible coordination of the quinoline 
substrate in the QOR active site, (a) anti-TS, and (b) syn-TS. 




Figure 4 The two postulated geometries of the XO : 
hypoxanthine transition state, (a) and (b), that are both 
subject to the condition that the substrate N=C and the 
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Figure 2b: in all transition states the substrate carbon atom 
undergoing oxidative hydroxylation has the (S)-absolute 
configuration. It thus seems that structural and configurat-
ional analysis of the Mo-enedithiolate : formamide model, 
supported by the crystal structures of the QOR : quinoline 
substrate complex and the XOR : pyridine-derivative 
inhibitor complex, suggests a model suitable for both  
the coordination of substrate and a location of a Brønsted-




Analysis of the electronic and molecular structure changes 
predicted for a model reaction of xanthine oxidoreductase 
with substrate reveals new reaction mechanistic 
parameters. Firstly, the molybdenum center in the enzyme 
active site acts as a chiral switch, changing the absolute 
configuration from (S)- in the fully oxidized state, Mo(VI), to 
the (R)-absolute configuration in the fully reduced state, 
Mo(IV). Secondly, this process is complemented by 
induction of chirality in the transition state in the reaction 
with a pro-chiral substrate formamide (pro-SC → SC). When 
extended to the conjugated heterocyclic substrates (e.g. 
purine, pteridine and quinoline), this observation suggests 
that protonation of the substrate imino nitrogen vicinal to 
the oxidized carbon center is a prerequisite for the sp2 – sp3 
re-hybridization of the carbon center and formation of 
transition state. The absolute configurations of the enzyme 
molybdenum center and the substrate carbon center 
further require that the substrate imino nitrogen be 
positioned anti- to the Mo=O ligand. This in turn requires a 
proton transfer from the protein and imposes coordination 
constraints on heterocyclic substrates. 
 The relevance of the approach presented here is 
potentially twofold: (i) it provides a basis for novel 
applications of signed optical spectroscopies in studies of 
kinetic and mechanistic properties of this class of enzymes 
(and this class of cofactors), and (ii) it recognizes the 
absolute configuration of the enzyme active site as a novel 
parameter suitable for classification of the structure and 
catalytic activity in molybdopterin oxidoreductive enzymes 
or possibly in metalloenzymes in general. 
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